Can a simple test predict immunotherapy success in blood cancer?
NCT ID NCT07018310
First seen Nov 20, 2025 · Last updated May 01, 2026 · Updated 24 times
Summary
This study aims to develop a simple blood test to measure how well a patient's immune cells can fight blood cancer. Researchers will collect blood samples from 166 adults with various blood cancers before they start treatment. The goal is to understand why immune cells sometimes fail to attack cancer, which could help doctors choose the best immunotherapy for each patient in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGICAL MALIGNANCY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Assisitance Publique Hôpitaux de Marseille
Marseille, 13005, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.